Funding opportunities
228 live opportunities from Grants.gov, NIH, NSF, and more.
Chemistry & Materials× remove
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)National Institutes of HealthPA-25-093 closes 1/7/2028postedgrants.gov
- Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)National Institutes of HealthPAR-25-024 closes 1/7/2028postedgrants.gov
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)National Institutes of HealthRFA-DA-26-034 closes 11/18/2027postedgrants.gov
- Replication Gap Suppression by Translesion Synthesis Promotes Drug Resistance in hard-to-treat cancersNational Cancer InstitutePA-26-001 closes 7/31/2027up to $3,000activenih
- BD FACSDiscover S8 Cell Sorter with Image-Based and Spectral Sorting Capabilities for Biomedical ResearchNIH Office of the DirectorPAR-24-265 closes 6/14/2027up to $703,181activenih
- LUMICKS C-Trap Edge 350NIH Office of the DirectorPAR-24-264 closes 6/14/2027up to $1,079,965activenih
- Octet-RH16 SystemNIH Office of the DirectorPAR-24-265 closes 6/14/2027up to $430,144activenih
- Optima Analytical Ultracentrifuge (AUC)NIH Office of the DirectorPAR-24-265 closes 5/31/2027up to $671,059activenih
- Developing Multi-Functional Dressings for Treating Chemical Vesicant-induced Skin InjuryNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 5/31/2027up to $387,449activenih
- Liquid-Chromatography Tandem Mass Spectrometry (LC-MS/MS) SystemNational Institute of General Medical SciencesPAR-23-138 closes 5/31/2027up to $250,000activenih
- DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment TrialNational Institute of Allergy and Infectious DiseasesPAR-18-633 closes 5/31/2027up to $44,991activenih
- Identifying arginylation inhibitors to attenuate injury-induced neuronal cell deathNational Institute of Neurological Disorders and StrokePAR-25-059 closes 5/31/2027up to $368,695activenih
- 2026 Thiol-Based Redox Regulation and Signaling Gordon Research Conference and Gordon Research SeminarNational Institute of Environmental Health SciencesPA-25-080 closes 5/31/2027up to $8,000activenih
- DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment TrialNational Institute of Allergy and Infectious DiseasesPAR-18-633 closes 5/31/2027up to $481,962activenih
- Facilitating the Advancement of Research and Education for Undergraduate Students by Incorporating Laser Scanning Confocal Microscopy (FAREUS-LSCM)National Institute of General Medical SciencesPAR-23-138 closes 5/31/2027up to $250,000activenih
- Multimode High-Throughput Screening Microplate ReaderNIH Office of the DirectorPAR-24-265 closes 5/31/2027up to $155,178activenih
- 2026 Chromatin Structure and Function Gordon Research Conference and Gordon Research SeminarNational Cancer InstitutePA-25-080 closes 5/31/2027up to $12,000activenih
- Winter Conference to Advance New Approach Methodologies (NAMs) in Chemosensory ScienceNational Institute on Deafness and Other Communication DisordersPA-25-080 closes 5/31/2027up to $60,000activenih
- Development of ClusterBuild to Synthesize Biosynthetic Gene ClustersNational Institute of General Medical SciencesPA-24-245 closes 5/31/2027up to $306,151activenih
- X-ray Macromolecular Crystallography Detector Upgrade for Structural Biology FacilityNIH Office of the DirectorPAR-24-265 closes 5/14/2027up to $565,073activenih
- 400 MHz NMR SpectrometerNIH Office of the DirectorPAR-24-265 closes 5/14/2027up to $450,305activenih
- Solid Phase Peptide SynthesizerNIH Office of the DirectorPAR-24-265 closes 5/14/2027up to $128,860activenih
- Comprehensive protein stability platformNIH Office of the DirectorPAR-24-265 closes 5/14/2027up to $199,667activenih
- Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)National Institutes of HealthPAR-27-081 closes 3/5/2027postedgrants.gov
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)National Institutes of HealthPAR-25-077 closes 10/16/2026postedgrants.gov